19 unchanged sentences
Based on our evaluation under the framework in Internal Control − Integrated Framework, management concluded that our internal control over financial reporting was effective as of December 31, 2025.
−Removed: Our independent registered public accounting firm, Ernst & Young LLP, has audited our Consolidated Financial Statements included in Item 8 of this Annual Report on Form 10-K and have issued a report on our internal control over financial reporting as of December 31, 2024.
+Added: Our independent registered public accounting firm, Ernst & Young LLP, has audited our Consolidated Financial Statements included in Item 8 of this Annual Report and have issued a report on our internal control over financial reporting as of December 31, 2025.
Their report on the audit of internal control over financial reporting appears below.
32 unchanged sentences
Directors, Executive Officers and Corporate Governance
−Removed: The information required by this Item will be set forth in our proxy statement to be filed with the Securities and Exchange Commission within 120 days after the end of our fiscal year ended December 31, 2024 (our “Proxy Statement”) and is incorporated into this Annual Report on Form 10-K by reference, specifically:
+Added: The information required by this Item will be set forth in our proxy statement to be filed with the Securities and Exchange Commission within 120 days after the end of our fiscal year ended December 31, 2025 (our "Proxy Statement") and is incorporated into this Annual Report by reference, specifically:
• Information regarding our directors and any persons nominated to become a director, as well as with respect to some other required board matters, is set forth under Proposal 1 entitled "Election of Directors" and under the caption "Corporate Governance."
6 unchanged sentences
We have adopted an insider trading policy governing the purchase, sale and other dispositions of our securities by our directors and employees that are designed to promote compliance with insider trading laws, rules and regulations, as well as procedures designed to further the foregoing purposes.
−Removed: A copy of our insider trading policy is filed with this Annual Report on Form 10-K as Exhibit 19.1.
+Added: A copy of our insider trading policy is included with this Annual Report as Exhibit 19.1.
Executive Compensation
−Removed: The information required by this Item will be set forth in our Proxy Statement under the captions “Executive Compensation,” “Compensation of Directors” and “Compensation Committee Interlocks and Insider Participation” and is incorporated into this Annual Report on Form 10-K by reference.
+Added: The information required by this Item will be set forth in our Proxy Statement under the captions "Executive Compensation," "Compensation of Directors" and "Compensation Committee Interlocks and Insider Participation" and is incorporated into this Annual Report by reference.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
−Removed: The information required by this Item will be set forth in our Proxy Statement under the caption “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information” and is incorporated into this Annual Report on Form 10-K by reference.
+Added: The information required by this Item will be set forth in our Proxy Statement under the caption "Security Ownership of Certain Beneficial Owners and Management" and "Equity Compensation Plan Information" and is incorporated into this Annual Report by reference.
Certain Relationships and Related Transactions, and Director Independence
−Removed: The information required by this Item will be set forth in our Proxy Statement under the captions “Related Person Transactions” and “Corporate Governance” and is incorporated into this Annual Report on Form 10-K by reference.
+Added: The information required by this Item will be set forth in our Proxy Statement under the captions "Related Person Transactions" and "Corporate Governance" and is incorporated into this Annual Report by reference.
Principal Accounting Fees and Services
−Removed: The information required by this Item will be set forth in our Proxy Statement under the Proposal with the caption “Ratification of Appointment of Independent Registered Public Accounting Firm” and is incorporated into this Annual Report on Form 10-K by reference.
+Added: The information required by this Item will be set forth in our Proxy Statement under the Proposal with the caption "Ratification of Appointment of Independent Registered Public Accounting Firm" and is incorporated into this Annual Report by reference.
Exhibits and Financial Statement Schedules
−Removed: (a) The following documents are filed as part of this Annual Report on Form 10-K:
+Added: (a) The following documents are filed as part of this Annual Report:
(1) Financial Statements
37 unchanged sentences
Letter Agreement, dated January 13, 2025, between the Registrant and Richard Markus, MD., Ph.D.
+Added: 10-K 001-38419 10.9 February 25, 2025
Arcus Biosciences, Inc.
59 unchanged sentences
1 to Option and License Agreement, dated September 19, 2017, between Arcus Biosciences, Inc.
−Removed: and Taiho Pharmaceutical Co, Ltd .
+Added: and Taiho Pharmaceutical Co .
10-Q 001-38419 10.1 November 8, 2018
2 unchanged sentences
10-Q 001-38419 10.1 November 7, 2023
+Added: Amendment No.
+Added: 2 to Option and License Agreement, dated October 17, 2025, between Arcus Biosciences, Inc.
+Added: and Taiho Pharmaceutical Co., LTD.
Option, License and Collaboration Agreement dated May 27, 2020 between Arcus Biosciences, Inc.
17 unchanged sentences
10-Q 001-38419 10.1 August 8, 2024
+Added: Amendment No.
+Added: 5 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc., and Gilead Scienc e s, Inc., dated November 5, 2025.
Letter Agreement with Gilead Sciences, Inc., dated July 1, 2022.
6 unchanged sentences
SC 13D/A 005-90423 99.2 January 31, 2024
−Removed: 10.40 Equity Distribution Agreement, dated as of February 28, 2023, by and among the Registrant, Goldman Sachs & Co.
−Removed: LLC and SVB Securities LLC.
−Removed: S-3 333-270132 1.2 February 28, 2023
10.42 Loan & Security Agreement, between the Registrant, Hercules Capital, Inc.
and the lenders listed therein, dated August 27, 2024
−Removed: 10-Q 001-38419 10.1 February 28, 2023
−Removed: Separation Agreement, between the Registrant and Dimitry Nuyten, dated January 16, 2025 .
+Added: 10-Q 001-38419 10.1 November 6, 2024
+Added: 10.43* First Amendment to Loan and Security Agreement, between the Registrant, Hercules Capital, Inc.
+Added: and the lenders listed therein, dated December 18, 2025.
19.1 Insider Trading Policy.
+Added: 10-K 001-38419 19.1 February 25, 2025
23.1* Consent of independent registered public accounting firm.
64 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.